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Pfs25 is a target protein for the induction of antibod­
ies that block transmission of Plasmodium falciparum. 
Anti-Pfs25 monoclonal antibody (mAb) 32F81 has been 
generated against gametes of strain NF54 and shown to 
block the oocyst development in mosquitoes fed on red  
blood cell suspensions containing NF54 gametocytes 
(V e r m e u l e n  et a l ,  1985). Comparison of the genes en ­
coding Pfs25 in 8 isolates of different geographical o ri­
gin showed almost complete sequence homology (KAS- 
LOW et a l 1989). Since transmission blocking activity of 
32F81 has been reported for NF54 only, we wanted to 
test the capacity of this mAb to block transmission of 
field isolates by experimentally feeding local Anopheles 
gambiae on blood from naturally infected carriers of P. 
falciparum gametocytes. mAb 32F81 was added to the  
blood meal at a concentration of 50 ¿¿g/mL. A blood 
meal from the same gametocyte carrier without the mAb 
was used as a control. Gametocyte density was estimated 
from the parasite/leucocyte ratio by counting gameto­
cytes against 1000 white blood cells and assuming an av­
erage leucocyte count of 8000//xL. In 5 mosquitoess fed 
on persons with >200 gametocytes per ¡iL, round forms 
(activated macrogametocytes and zygotes) were searched
Table. Infections of Anopheles gambiae fed on whole blood samples 
from 13 Plasmodium falciparum gametocyte carriers in the presence 
and absence of monoclonal antibody 32F81
Control 32F8I
Gametocyte No. of No.
number/ No. Percentage oocysts No. Percentage oocysts 
mm3 ___  dissected infected (mean^ dissected infected (mean)
8 30 23*3 1-3 30 0 -
48 50 22*0 1-3 36 0 —
96 26 7*7 1*0 22 0 —
96 30 16*7 5*2 30 3*3 1*0
136 50 74*0 2*6 50 0 —
168 30 56*7 2*6 30 16*7 1*6
248 30 10*0 1*0 30 3*3 2*0
296 50 10*0 1-8 30 0 —
360 28 35*7 7*4 19 0 —
544 50 14*0 3*1 50 0 —
652 50 90*0 32*9 50 80 4-3
1000 25 36*0 10*2 30 3*3 2*0
1240 47 59-6 16*7 21 14*3 1*3
for 4 h  after the blood meal, using mAb 32F81 labelled 
with fluorescein isothiocyanate. Ookinetes were also 
looked for in 5 mosquitoes 24 h after the blood meal. Af­
ter 7 d? surviving mosquitoes were examined for the  
presence and num ber of oocysts. Thirty-three infection 
experiments were performed and 2292 mosquitoes were 
dissected. T h e  mean age of the gametocyte carriers was
20-3 years (range 4—44 years) and the  m ean gametocyte 
density was 252/mm3. Mean num bers  (per m m 3) of 
round forms (10*4±9*6) and ookinetes (0-6±l*3) were 
lower in  the 32F81 group, but no t s ignificantly  so,, th an  
in the  control group (18*7±26*7 and  9*0±20*1, respec­
tively), Blood meals from 13 gametocyte carriers gave 
rise to oocysts (Table). Their mean age was 18-5 years 
and th e ir  mean gametocyte density was 400/m m 3, In  the  
experimental group 430 mosquitoes were dissected^ and  
in the  control group 498. The m ean percentage o f  oo­
cyst-infected mosquitoes in the control group was 35, 
while in  those fed on blood contain ing m A b 32F81 it 
was 3'75 CPcO-002) M ann-W hitney  U  test), .While the 
mean oocyst num ber in  the control group was over 7, the 
32F81 experimental group yielded a m ean  of less than  
one oocyst per mosquito (P<0*003, M a n n -W h itn e y  U  
test). T h e  3 subjects with the highest gametocyte n u m ­
bers showed significantly higher infection percentages 
even in  the 32F81 group (P<0*05 M a n n -W h itn e y  U  
test)>
We conclude that mAb 32F81 can block transm ission  
from naturally infected P. falciparum gametocyte carriers 
to a local strain o f  A. gambiae, as has been show n by VER­
MEULEN et al. (1985) and  MULDER et a l  (1994) for a labo- 
ratory-adapted strain o i  P. falcipamm. T hese  findings are 
in agreement with the almost complete genetic hom ol­
ogy o f  Pfs25 in different isolates, w hich  has been consid­
ered to support the development o f  a transm ission- 
blocking vaccine based on this protein . T ransm iss ion  
blocking is more effective at low gam etocyte densities, 
which are prevalent under natural conditions, and th is  
confirms previous findings in experim ental infections 
(PONNUDURAI et al,, 1987). In addition  to naturally  oc­
curring transmission blockage of P. fa lcipam m  in  en ­
demic countries ( M u l d e r  et a l 1994), im m uniza tion  
using a Pfs25 vaccine might fu r the r  reduce malaria 
transmission ( K a s lo w  e ta i,  1991; K a s l o w ,  1993).
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